BioAssay Ontology
Names
More detailed information about this field from each metasource.
BioAssay Ontology
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
BAO
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
Names
More detailed information about this field from each metasource.
BioAssay Ontology
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
BAO
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
Names
More detailed information about this field from each metasource.
BioAssay Ontology
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
BAO
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
The BioAssay Ontology (BAO) describes chemical biology screening assays and their results including high-throughput screening (HTS) data for the purpose of categorizing assays and data analysis.
Description
More detailed information about this field from each metasource.
The BioAssay Ontology (BAO) describes chemical biology screening assays and their results including high-throughput screening (HTS) data for the purpose of categorizing assays and data analysis.
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
The BioAssay Ontology (BAO) describes chemical biology screening assays and their results including high-throughput screening (HTS) data for the purpose of categorizing assays and data analysis. BAO is an extensible, knowledge-based, highly expressive (currently SHOIQ(D)) description of biological assays making use of descriptive logic based features of the Web Ontology Language (OWL). BAO currently has over 1000 classes and also makes use of several other ontologies. It describes several concepts related to biological screening, including Perturbagen, Format, Meta Target, Design, Detection Technology, and Endpoint. Perturbagens are perturbing agents that are screened in an assay; they are mostly small molecules. Assay Meta Target describes what is known about the biological system and / or its components interrogated in the assay (and influenced by the Perturbagen). Meta target can be directly described as a molecular entity (e.g. a purified protein or a protein complex), or indirectly by a biological process or event (e.g. phosphorylation). Format describes the biological or chemical features common to each test condition in the assay and includes biochemical, cell-based, organism-based, and variations thereof. The assay Design describes the assay methodology and implementation of how the perturbation of the biological system is translated into a detectable signal. Detection Technology relates to the physical method and technical details to detect and record a signal. Endpoints are the final HTS results as they are usually published (such as IC50, percent inhibition, etc.). BAO has been designed to accommodate multiplexed assays. All main BAO components include multiple levels of sub-categories and specification classes, which are linked via object property relationships forming an expressive knowledge-based representation.
metasource: Biontology / Bioportalversion: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
Webpage:
http://bioassayontology.orgWebpage
More detailed information about this field from each metasource.
http://bioassayontology.org
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
http://www.bioassayontology.org/
metasource: Biontology / Bioportalversion: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
Licence:
Name: Creative Commons Attribution 4.0 International (CC BY 4.0)Licence name
More detailed information about this field from each metasource.
Creative Commons Attribution 4.0 International (CC BY 4.0)
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
This ontology is made available under the Creative Commons Attribution-ShareAlike 4.0 International (CC by SA4) license.
metasource: Biontology / Bioportalversion: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
Licence URL
More detailed information about this field from each metasource.
https://creativecommons.org/licenses/by/4.0/
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
https://creativecommons.org/licenses/by-sa/4.0/
metasource: Biontology / Bioportalversion: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
Publications:
Publications
More detailed information about this field from each metasource.
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
PMID: 21702939
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
Evolving BioAssay Ontology (BAO): modularization, integration and applications
PMID: 25093074
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
Digitoxin metabolism by rat liver microsomes
PMID: 10
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO)
PMID: 23155465
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
http://www.bioassayontology.org/
metasource: Biontology / Bioportal
version: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
Publications
More detailed information about this field from each metasource.
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
PMID: 21702939
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
Evolving BioAssay Ontology (BAO): modularization, integration and applications
PMID: 25093074
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
Digitoxin metabolism by rat liver microsomes
PMID: 10
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO)
PMID: 23155465
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
http://www.bioassayontology.org/
metasource: Biontology / Bioportalversion: 2.7.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/BAO
-
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
PubMed citations: 51.
51 articles citing: BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal. PMID:34060634
The Life of a Trailing Spouse. PMID:33408132
Your Spreadsheets Can Be FAIR: A Tool and FAIRification Workflow for the eNanoMapper Database. PMID:32987901
BioHackathon 2015: Semantics of data for life sciences and reproducible research. PMID:32308977
Machine and deep learning approaches for cancer drug repurposing. PMID:31904426
Identification of Compounds That Interfere with High-Throughput Screening Assay Technologies. PMID:31479198
Data Mining Approach for Extraction of Useful Information About Biologically Active Compounds from Publications. PMID:31453694
Improving the Utility of the Tox21 Dataset by Deep Metadata Annotations and Constructing Reusable Benchmarked Chemical Reference Signatures. PMID:31018579
How to Develop a Drug Target Ontology: KNowledge Acquisition and Representation Methodology (KNARM). PMID:30848456
Sharing and reusing cell image data. PMID:29851565
VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization. PMID:28978313
A rule-based named-entity recognition method for knowledge extraction of evidence-based dietary recommendations. PMID:28644863
Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery. PMID:28274840
Large-scale bioactivity analysis of the small-molecule assayed proteome. PMID:28178331
PubChem BioAssay: 2017 update. PMID:27899599
The ChEMBL database in 2017. PMID:27899562
Automated detection of discourse segment and experimental types from the text of cancer pathway results sections. PMID:27580922
The BioHub Knowledge Base: Ontology and Repository for Sustainable Biosourcing. PMID:27246819
RegenBase: a knowledge base of spinal cord injury biology for translational research. PMID:27055827
Module Extraction for Efficient Object Queries over Ontologies with Large ABoxes. PMID:26848490
Standardization of high content imaging and informatics. PMID:26317882
Activity, assay and target data curation and quality in the ChEMBL database. PMID:26201396
Reporting biological assay screening results for maximum impact. PMID:26194585
A large-scale crop protection bioassay data set. PMID:26175909
eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment. PMID:25815161
A bioinformatics expert system linking functional data to anatomical outcomes in limb regeneration. PMID:25729585
BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result types. PMID:25477388
Databases and collaboration require standards for human stem cell research. PMID:25449658
Parallel worlds of public and commercial bioactive chemistry data. PMID:25415348
PubChem applications in drug discovery: a bibliometric analysis. PMID:25168772
Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation. PMID:25165633
Evolving BioAssay Ontology (BAO): modularization, integration and applications. PMID:25093074
The Software Ontology (SWO): a resource for reproducibility in biomedical data analysis, curation and digital preservation. PMID:25068035
Thematic series on biomedical ontologies in JBMS: challenges and new directions. PMID:24602198
Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High-Throughput Screening Data from the Library of Integrated Network-based Cellular Signatures (LINCS). PMID:24518066
An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines. PMID:24441647
The ChEMBL bioactivity database: an update. PMID:24214965
GPCR ontology: development and application of a G protein-coupled receptor pharmacology knowledge framework. PMID:24078711
The ChEMBL database as linked open data. PMID:23657106
PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery. PMID:23548981
Towards a bioinformatics of patterning: a computational approach to understanding regulative morphogenesis. PMID:23429669
Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. PMID:23338806
Mining collections of compounds with Screening Assistant 2. PMID:23327565
Annotating Human P-Glycoprotein Bioassay Data. PMID:23293680
Taking Open Innovation to the Molecular Level - Strengths and Limitations. PMID:23226167
Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO). PMID:23155465
On the ontology based representation of cell lines. PMID:23144907
The Units Ontology: a tool for integrating units of measurement in science. PMID:23060432
Effects of psychological stress on innate immunity and metabolism in humans: a systematic analysis. PMID:23028447
Structure-based classification and ontology in chemistry. PMID:22480202
Improving integrative searching of systems chemical biology data using semantic annotation. PMID:22401035 -
Evolving BioAssay Ontology (BAO): modularization, integration and applications
PubMed citations: 40.
40 articles citing: Evolving BioAssay Ontology (BAO): modularization, integration and applications
The AOP-DB RDF: Applying FAIR Principles to the Semantic Integration of AOP Data Using the Research Description Framework. PMID:35295213
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments. PMID:34472587
MetamORF: a repository of unique short open reading frames identified by both experimental and computational approaches for gene and metagene analyses. PMID:34156446
IDSM ChemWebRDF: SPARQLing small-molecule datasets. PMID:33980298
The Life of a Trailing Spouse. PMID:33408132
Your Spreadsheets Can Be FAIR: A Tool and FAIRification Workflow for the eNanoMapper Database. PMID:32987901
Machine and deep learning approaches for cancer drug repurposing. PMID:31904426
Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels. PMID:31783775
Data Management in Computational Systems Biology: Exploring Standards, Tools, Databases, and Packaging Best Practices. PMID:31602618
Progress in data interoperability to support computational toxicology and chemical safety evaluation. PMID:31404555
Improving the Utility of the Tox21 Dataset by Deep Metadata Annotations and Constructing Reusable Benchmarked Chemical Reference Signatures. PMID:31018579
How to Develop a Drug Target Ontology: KNowledge Acquisition and Representation Methodology (KNARM). PMID:30848456
Enhanced taxonomy annotation of antiviral activity data from ChEMBL. PMID:30753475
ChEMBL: towards direct deposition of bioassay data. PMID:30398643
A large-scale dataset of in vivo pharmacology assay results. PMID:30351302
Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles. PMID:30219839
Extending in Silico Protein Target Prediction Models to Include Functional Effects. PMID:29942259
Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center. PMID:29917015
A guideline for reporting experimental protocols in life sciences. PMID:29868256
The eXtensible ontology development (XOD) principles and tool implementation to support ontology interoperability. PMID:29329592
Ontological representation, integration, and analysis of LINCS cell line cells and their cellular responses. PMID:29322930
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions. PMID:29276046
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. PMID:29149325
Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data. PMID:29140462
Using semantics for representing experimental protocols. PMID:29132408
Drug target ontology to classify and integrate drug discovery data. PMID:29122012
SourceData: a semantic platform for curating and searching figures. PMID:29088127
Dietary and health biomarkers-time for an update. PMID:28974991
Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery. PMID:28274840
The ChEMBL database in 2017. PMID:27899562
BIGCHEM: Challenges and Opportunities for Big Data Analysis in Chemistry. PMID:27464907
RegenBase: a knowledge base of spinal cord injury biology for translational research. PMID:27055827
Accelerating Adverse Outcome Pathway Development Using Publicly Available Data Sources. PMID:26809562
The eNanoMapper database for nanomaterial safety information. PMID:26425413
Standardization of high content imaging and informatics. PMID:26317882
Activity, assay and target data curation and quality in the ChEMBL database. PMID:26201396
Reporting biological assay screening results for maximum impact. PMID:26194585
QSAR Modeling Using Large-Scale Databases: Case Study for HIV-1 Reverse Transcriptase Inhibitors. PMID:26046311
The role of ontologies in biological and biomedical research: a functional perspective. PMID:25863278
Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation. PMID:25165633 -
Digitoxin metabolism by rat liver microsomes
PubMed citations: 34.
34 articles citing: Digitoxin metabolism by rat liver microsomes
Spinal cord injury during selective cerebral perfusion and segmental artery occlusion: an experimental study. PMID:34999799
An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis. PMID:34885662
Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy. PMID:34721764
Indications and outcomes of endoscopic resection for non-pedunculated colorectal lesions: A narrative review. PMID:34512876
Polarized Secretion of APRIL by the Tonsil Epithelium Upon Toll-Like Receptor Stimulation. PMID:34484218
Recent Status and Prospects on Thermochemical Heat Storage Processes and Applications. PMID:34441093
A Widespread Bacterial Secretion System with Diverse Substrates. PMID:34399622
From clinical trials to clinical practice: How long are drugs tested and then used by patients? PMID:34389867
Quantifying the invasion and migration ability of cancer cells with a 3D Matrigel drop invasion assay. PMID:34377838
Nutrient Deficiency and an Algicidal Bacterium Improved the Lipid Profiles of a Novel Promising Oleaginous Dinoflagellate, Prorocentrum donghaiense, for Biodiesel Production. PMID:34319787
Validation of the MYChrOme™ Culture Plate for Detection and Differentiation of Rapid-Growing Nontuberculous Mycobacteria in Potable and Non-Potable Water: AOAC Performance Tested MethodSM 062101. PMID:34297095
Preferences for Digital Smartphone Mental Health Apps Among Adolescents: Qualitative Interview Study. PMID:34128814
"Doc McStuffins: Doctor for a Day" Virtual Reality (DocVR) for Pediatric Preoperative Anxiety and Satisfaction: Pediatric Medical Technology Feasibility Study. PMID:33730687
TDCS effects on pointing task learning in young and old adults. PMID:33564052
Cyclin-dependent kinase inhibitors p21 and p27 function as critical regulators of liver regeneration following 90% hepatectomy in the rat. PMID:33442448
[Roles of autophagy onself-renewal and differentiation of mesenchymal stem cells]. PMID:33377351
Mutations in two ERAD E3 ubiquitin ligase enzymes reduce spontaneous reversal frequency in Caenorhabditis elegans. PMID:33274327
Development of a Novel Electrochemical Biosensor Based on Carbon Nanofibers-Gold Nanoparticles-Tyrosinase for the Detection of Ferulic Acid in Cosmetics. PMID:33255463
Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections. PMID:32849627
Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study. PMID:32573355
Role of the p38 MAP kinase pathway in C. elegans surface antigen switching. PMID:32550455
C. elegans srf-6 and nsy-1 mutations result in a similar 2AWCON phenotype and do not complement (srf-6 is nsy-1 II). PMID:32550425
Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. PMID:32104551
Paradox of hypercholesterolaemia in highly trained, keto-adapted athletes. PMID:30305928
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. PMID:29359013
Website Use and Effects of Online Information About Tobacco Additives Among the Dutch General Population: A Randomized Controlled Trial. PMID:28292739
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment. PMID:27081636
Management of hepatitis B virus infection after liver transplantation. PMID:26576093
Succinate dehydrogenase-deficient gastrointestinal stromal tumors. PMID:25741136
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. PMID:25206258
Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion. PMID:24340137
Electrocorticographic sensorimotor mapping. PMID:23601701
Increased digitoxin cleavage by liver microsomes of spironolactone-pretreated rats. PMID:740054
Dehydro-digitoxosides of digitoxigenin: formation and importance for the digitoxin metabolism in the rat. PMID:732892 -
Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO)
PubMed citations: 26.
26 articles citing: Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO)
MolData, a molecular benchmark for disease and target based machine learning. PMID:35255958
The Life of a Trailing Spouse. PMID:33408132
Machine and deep learning approaches for cancer drug repurposing. PMID:31904426
Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels. PMID:31783775
Progress in data interoperability to support computational toxicology and chemical safety evaluation. PMID:31404555
Improving the Utility of the Tox21 Dataset by Deep Metadata Annotations and Constructing Reusable Benchmarked Chemical Reference Signatures. PMID:31018579
A large-scale dataset of in vivo pharmacology assay results. PMID:30351302
Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds. PMID:29990427
Extending in Silico Protein Target Prediction Models to Include Functional Effects. PMID:29942259
Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center. PMID:29917015
Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data. PMID:29140462
Drug target ontology to classify and integrate drug discovery data. PMID:29122012
First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine. PMID:27405781
Badapple: promiscuity patterns from noisy evidence. PMID:27239230
Database: A New Article Type in CPT: Pharmacometrics & Systems Pharmacology. PMID:26380152
Reporting biological assay screening results for maximum impact. PMID:26194585
A Data Analysis Pipeline Accounting for Artifacts in Tox21 Quantitative High-Throughput Screening Assays. PMID:25904095
CLO: The cell line ontology. PMID:25852852
Screening of cell cycle fusion proteins to identify kinase signaling networks. PMID:25606665
BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result types. PMID:25477388
Assessing HTS performance using BioAssay Ontology: screening and analysis of a bacterial phospho-N-acetylmuramoyl-pentapeptide translocase campaign. PMID:25415593
Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation. PMID:25165633
Evolving BioAssay Ontology (BAO): modularization, integration and applications. PMID:25093074
Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High-Throughput Screening Data from the Library of Integrated Network-based Cellular Signatures (LINCS). PMID:24518066
An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines. PMID:24441647
GPCR ontology: development and application of a G protein-coupled receptor pharmacology knowledge framework. PMID:24078711 - http://www.bioassayontology.org/
Tags:
Tags
More detailed information about this field from each metasource.
assay
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
biological process
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
cell
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
chemical entity
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
molecular entity
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
protein
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
reagent
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
target
metasource: Fairsharing.org
version: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
Tags
More detailed information about this field from each metasource.
assay
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
biological process
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
cell
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
chemical entity
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
molecular entity
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
protein
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
reagent
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
target
metasource: Fairsharing.orgversion: FAIRsharing.org: BAO; BioAssay Ontology; DOI: https://doi.org/10.25504/FAIRsharing.mye76w; Last edited: Feb. 27, 2020, 11:19 a.m.; Last accessed: Jan 03 2022 7:13 p.m.
assay biological process cell chemical entity molecular entity protein reagent target
Need help integrating and/or managing biomedical data?